ATS 2024 Final Program

Click on the session title to view the speakers

38

SUNDAY • MAYs 19

P338 Glutamine-mediated Changes in the Activity of Alveolar and Bone Marrow-derived Macrophages P339 Three-dimensional Label-free Morphology of T Cells as a Biomarker for Immune Status in Lung Transplantation Patients P340 Bronchoalveolar Lavage Fluid Eosinophilia Is Associated With Worse Outcomes After Lung Transplant P341 Exertion of Lung TRM CD4 + T Cells Might Ameliorate Pulmonary Nontuberculous Mycobacterial Disease P342 Piezo1 Ca 2+ Channel Activity Is Augmented by P. Aeruginosa Flagellin Through TLR5-MyD88 to Promote RAC1-dependent Bacterial Clearance P343 Single-cell RNA Sequencing Analysis Identifies Long-term Alterations in Lung Epithelial Cell Distribution and Phenotype After EL-RSV Infection P344 The Anti-inflammatory Interaction of Human Surfactant Protein D (SP-D) With Monocyte-derived Dendritic Cells in Allergic Asthma P345 The Complex Interplay Between Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling, Gut-lung Microbiome Axis and Bariatric Surgery in Obese, Chronically Allergen-challenged Mice P346 Patient-Level Insights into Maintenance of Good Inhaler Technique Over Time With Use of a Digihaler System P347 Intrapulmonary T Cells Are Sufficient for Schistosoma-induced Pulmonary Hypertension P348 Gut Barrier Dysfunction From Chronic Binge Alcohol Influences the Lung Response to Infection P349 T Cell Responses to Valley Fever P350 Lung Interstitial Macrophage Responses During and After Recovery From Pneumococcal Respiratory Infection P351 Inhibition of Inflammation and Fibrosis by Febuxostat Administration in a Mouse Model of LPS-induced Lung Injury P352 Early Diagnosis for Bordetella Pertussis and Bordetella Parapertussis Infection With Pertussis Antibody IgM, IgA, and IgM/IgA Ratio

P353 When Control Mortality Rate Is High, Nicotinamide (NAM) Treatment Reduces Weight Loss and Increases Survival in a Mouse Hepatitis Virus-1 (MHV-1) Challenged Mouse Pneumonia Model: Results of a Randomized and Blinded Exploratory Study P354 Pulmonary and Hemodynamic Effects of Intratracheal Challenge With Rat Sialodacryoadenitis Coronavirus (RCoV-SDAV) in a Rat Pneumonia Model P355 The Effects of Nicotinamide Adenine Dinucleotide (NAD) Metabolite Treatment in Animal Models of Microbial and Microbial Toxin Challenges: A Systematic Review and Meta-analysis P356 Elucidating PERK Mediated Cytokine Release During Influenza Infection P357 Analysis of Murine Stool Reveals Significant Alteration of the Fecal Metabolome in Tryptophan Metabolism

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A32 BENCH TO BEDSIDE IN ILD 9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area L (Hall H, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P1339 Clinical Factors for Development of Rheumatoid Arthritis in the Interstitial Lung Disease Cohort With Anti-cyclic Citrullinated Peptide Antibody P1340 Baseline Characteristics of Patients Enrolled in FIBRONEER™-IPF, A Phase III Randomized Placebo-controlled Trial of the Preferential PDE4B Inhibitor Nerandomilast (BI 1015550) in Patients With Idiopathic Pulmonary Fibrosis P1341 A Unique Phenotype of Sarcoidosis With Elevated Serum IgG4 P1342 Automated 3D Body Composition Analysis (BCA) as a Potential Predictor of Overall Survival in Patients With Nonspecific Interstitial Pneumonia (NSIP)

ATS 2024 Conference Program • San Diego, CA